Wild-type, but not mutant-type, p53 enhances nuclear accumulation of the NS3 protein of hepatitis C virus

被引:30
作者
Ishido, S [1 ]
Muramatsu, S [1 ]
Fujita, T [1 ]
Iwanaga, Y [1 ]
Tong, WY [1 ]
Katayama, Y [1 ]
Itoh, M [1 ]
Hotta, H [1 ]
机构
[1] KOBE UNIV,SCH MED,DEPT MICROBIOL,CHUO KU,KOBE,HYOGO 650,JAPAN
关键词
D O I
10.1006/bbrc.1996.5980
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By using vaccinia virus-T7 hybrid expression system, subcellular localization of the NS3 protein of hepatitis C virus was studied. Full-size NS3 (NS3F) and a carboxy-terminally truncated form (NS3 Delta C) were localized in the cytoplasm and the nucleus when expressed alone. However, NS3F and NS3 Delta C, but not amino- and carboxy-terminally truncated form (NS3 Delta N Delta C), were each co-localized with wild-type p53 almost exclusively in the nucleus upon co-expression. The wild-type p53-induced nuclear accumulation of NS3F was inhibited only partially by NS4A. When co-expressed with mutant-type p53, NS3F and NS3 Delta C were each co-localized with it exclusively in the cytoplasm. Taken together, the present results suggest that wild-type p53 enhances nuclear accumulation of NS3F and NS3 Delta C through the involvement of their amino-terminal sequences even in the presence of NS4A, and that mutant-type p53 inhibits their nuclear, and enhances their cytoplasmic, accumulation. (C) 1997 Academic Press
引用
收藏
页码:431 / 436
页数:6
相关论文
共 27 条
[1]   DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[2]   Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6 [J].
Doi, H ;
Apichartpiyakul, C ;
Ohba, K ;
Mizokami, M ;
Hotta, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :569-574
[3]   EUKARYOTIC TRANSIENT-EXPRESSION SYSTEM BASED ON RECOMBINANT VACCINIA VIRUS THAT SYNTHESIZES BACTERIOPHAGE-T7 RNA-POLYMERASE [J].
FUERST, TR ;
NILES, EG ;
STUDIER, FW ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) :8122-8126
[4]  
FUJITA T, 1996, IN PRESS BIOCH BIOPH
[5]  
GANNON JV, 1991, NATURE, V349, P802
[6]   EXPRESSION AND IDENTIFICATION OF HEPATITIS C VIRUS POLYPROTEIN CLEAVAGE PRODUCTS [J].
GRAKOUI, A ;
WYCHOWSKI, C ;
LIN, C ;
FEINSTONE, SM ;
RICE, CM .
JOURNAL OF VIROLOGY, 1993, 67 (03) :1385-1395
[7]   ACTIVATION OF EPSTEIN-BARR-VIRUS LATENT GENES PROTECTS HUMAN B-CELLS FROM DEATH BY APOPTOSIS [J].
GREGORY, CD ;
DIVE, C ;
HENDERSON, S ;
SMITH, CA ;
WILLIAMS, GT ;
GORDON, J ;
RICKINSON, AB .
NATURE, 1991, 349 (6310) :612-614
[8]   CELL-CYCLE CONTROL AND CANCER [J].
HARTWELL, LH ;
KASTAN, MB .
SCIENCE, 1994, 266 (5192) :1821-1828
[9]   DETECTION OF HEPATITIS-C VIRUS-RNA IN LIVER-TISSUES BY AN INSITU HYBRIDIZATION TECHNIQUE [J].
HARUNA, Y ;
HAYASHI, N ;
HIRAMATSU, N ;
TAKEHARA, T ;
HAGIWARA, H ;
SASAKI, Y ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
JOURNAL OF HEPATOLOGY, 1993, 18 (01) :96-100
[10]   INDUCTION OF BCL-2 EXPRESSION BY EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 PROTECTS INFECTED B-CELLS FROM PROGRAMMED CELL-DEATH [J].
HENDERSON, S ;
ROWE, M ;
GREGORY, C ;
CROOMCARTER, D ;
WANG, F ;
LONGNECKER, R ;
KIEFF, E ;
RICKINSON, A .
CELL, 1991, 65 (07) :1107-1115